Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dersalazine (Dersalazine Free Base) 是血小板活化因子抑制剂,通过下调 IL-17表达,在不同啮齿动物型结肠炎中发挥肠道抗炎活性,对溃疡性结肠炎患者具有潜在疗效。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,460 | 现货 | ||
5 mg | ¥ 3,670 | 现货 | ||
10 mg | ¥ 5,280 | 现货 | ||
25 mg | ¥ 8,190 | 现货 | ||
50 mg | ¥ 10,800 | 现货 | ||
100 mg | ¥ 14,900 | 现货 | ||
500 mg | ¥ 29,900 | 现货 |
产品描述 | Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis. |
体内活性 | Dersalazine sodium (DS) (10 or 30 mg/kg; b.i.d.; rats), when administered for 7 days, showed intestinal anti-inflammatory effects in TNBS-induced colitis; these effects were observed both macroscopically and through the profile of inflammatory mediators (TNF, IL-1β, IL-6, and IL-17). Although the 2 day treatment with DS did not induce intestinal anti-inflammatory effects, it was sufficient to reduce the enhanced IL-17 expression. DS showed beneficial effects on DSS-induced colitis in C57BL/6 mice and reduced colonic pro-inflammatory cytokines IL-1β, IL-6, and IL-17.[2] |
别名 | Dersalazine Free Base |
分子量 | 600.67 |
分子式 | C35H32N6O4 |
CAS No. | 188913-58-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: < 1mg/ml (insoluble)
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Dersalazine 188913-58-8 Immunology/Inflammation Others IL Receptor Platelet aggregation Dersalazine Free Base Inhibitor inhibitor inhibit